MoneyWorks4Me

Norris Medicines - Quaterly Results

10 Aug 2023 Evaluate
Revenue showed a marginal decline at Rs. 9.46 millions. For the quarter ended June 2023, as compared to corresponding quarter of last year.The Net Loss for the quarter ended June 2023 is Rs. -6.15 millions as compared to Net Loss of Rs. -4.39 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 further decreased to -3.86% as compared to -1.95% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 9.46 9.53 -0.73 9.46 9.53 -0.73 83.58 94.38 -11.44
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.26 -46.15
PBIDT -3.86 -1.95 97.95 -3.86 -1.95 97.95 9.38 -0.46 -2139.13
Interest 0.86 0.93 -7.53 0.86 0.93 -7.53 15.00 14.82 1.21
PBDT -4.72 -2.88 63.89 -4.72 -2.88 63.89 -5.62 -15.28 -63.22
Depreciation 1.43 1.51 -5.30 1.43 1.51 -5.30 6.30 6.57 -4.11
PBT -6.15 -4.39 40.09 -6.15 -4.39 40.09 -11.92 -21.85 -45.45
TAX 0.00 0.00 0.00 0.00 0.00 0.00 5.56 10.79 -48.47
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 5.56 10.79 -48.47
PAT -6.15 -4.39 40.09 -6.15 -4.39 40.09 -17.48 -32.64 -46.45
Equity 99.26 99.26 0.00 99.26 99.26 0.00 99.26 99.26 0.00
PBIDTM(%) -40.80 -20.46 99.41 -40.80 -20.46 99.41 11.22 -0.49 -2402.59
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..